Physician profile
Daniela Mihova
NPI 1205090412
$281.30
in general payments reported to CMS, 2019-2025
8 companies · $39.29 in 2025
The $39.29 reported for 2025 was less than what a typical Anatomic Pathology & Clinical Pathology provider received nationally (typical 2025 total: $50.59).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.13 · 2021: $23.06 · 2022: $89.98 · 2023: $26.76 · 2024: $16.08 · 2025: $39.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $82.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $82.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $86.13 | 2019 | |
| Roche Diagnostics Corporation | $62.35 | 2021-2025 | Benchmark Ultra, Iscan Coreo |
| Foundation Medicine, INC. | $36.22 | 2022-2023 | Foundationone Cdx |
| Lilly USA, LLC | $30.25 | 2022-2024 | |
| Biocartis US, INC | $25.57 | 2022 | |
| Merck Sharp & Dohme LLC | $16.18 | 2022 | |
| Genentech USA, INC. | $15.35 | 2022 | |
| Werfen USA LLC | $9.25 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniela Mihova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.